Conox-Guided Anesthesia in Pediatric Adenotonsillectomy

Condition(s) studied

Investigational drug(s) / intervention(s)

Conox Monitor: EEG-based monitoring device providing qCON and qNOX indices to guide anesthetic depth and analgesia.

Standard Anesthesia Monitoring: Anesthesia management based on conventional clinical parameters such as heart rate and blood pressure.

Study summary

This study aims to evaluate the effect of Conox (qCON/qNOX)-guided anesthesia on intraoperative anesthetic drug consumption and postoperative outcomes in pediatric patients undergoing adenotonsillectomy. Conox is a non-invasive EEG-based monitoring system that provides indices of both hypnosis and nociception.

In this randomized controlled trial, children aged 3-12 years will be assigned to either a Conox-guided anesthesia group or a standard monitoring group. The primary outcome of the study is total intraoperative opioid consumption, assessed from anesthesia induction to the end of surgery. Secondary outcomes include emergence time, extubation time, postoperative agitation, pain scores, and correlation between qCON/qNOX values and hemodynamic parameters.

Eligibility

Primary outcome measure(s)

• Total Intraoperative Opioid Consumption — Intraoperative period
  Total cumulative opioid dose administered from induction of anesthesia until the end of surgery.

Trial sites (1)

More Kayseri City Hospital trials in Turkey

Other trials for the same condition